Inflammation, Immunity and Redox Signaling by Joshua Jabaut & Karina Ckless
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
  
7 
Inflammation, Immunity and Redox Signaling 
Joshua Jabaut and Karina Ckless 
State University of New York at Plattsburgh (SUNY Plattsburgh),  
Chemistry Department 
USA 
1. Introduction 
It has long been known that several types of antioxidants also possess anti-inflammatory 
properties indicating a strong relationship between inflammation and oxidative stress. 
Reactive oxygen species (ROS) generated by inflammatory cells not only help to kill 
pathogens but also act on the inflammatory cells themselves, altering the intracellular redox 
balance and functioning as signaling molecules involved with the regulation of 
inflammatory and immunomodulatory genes. Indeed, at the transcriptional level, ROS play 
a key role in the control of nuclear factor kappa B (NF-B), activator protein-1 (AP-1), and 
other transcription factors involved in gene expression of both inflammatory and immune 
mediators. More interestingly, ROS and also reactive nitrogen species (RNS) can either 
activate or inactivate these transcription factors by chemically modifying critical amino acid 
residues within these proteins or on residues of accessory proteins of the respective 
signaling pathways. The interest in the molecular mechanisms involved in redox regulation 
of inflammatory and immune responses has gone beyond the transcription factors as target 
proteins. Proteins involved in signaling cascades that ultimately culminate in the production 
of inflammatory and immune mediators have been investigated as redox sensors and 
therefore targets for ROS and or RNS modulation. For instance, NLRP3 inflammasome is a 
cysteine-rich multidimeric protein that participates in the formation of a molecular platform 
for caspase1-dependent IL-1 secretion. It has been suggested that IL-1 production and 
secretion in monocytes is a redox regulated event. However, the mechanisms of production 
and the nature of ROS involved in inflammasome activation are still unknown. This chapter 
will discuss some of the latest concepts on how ROS and RNS can modulate the 
inflammatory and immune responses at the molecular level, from redox regulated 
transcription factors to redox sensitive proteins involved in inflammatory and immune 
signaling pathways. 
2. Chemistry, source and biological activity of reactive oxygen and nitrogen 
species 
By definition, free radicals are reactive molecules that can exist independently and have one 
or more unpaired electrons (Halliwell and Gutteridge 2007). On the other hand the term 
“oxidant” is used in reference to any substance that can abstract an electron or hydrogen 
atom from other molecules, regardless of having an unpaired electron. These chemical 
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species readily react with macromolecules in the biological systems by oxidizing them. In 
addition, they can react with metals, other oxidants, and reducing substances found in the 
intracellular milieu and generate many other reactive species. Within cells, “free radicals” 
and other oxidants can be formed by several sources, include enzymatic and non-enzymatic 
and also as a byproduct of biochemical reactions. Because of the complexity of the chemistry 
of these species, especially in biological systems, the terms reactive oxygen species (ROS) 
and reactive nitrogen species (RNS) will be used in this chapter to refer to the species that 
are derived from oxygen or nitrogen respectively. ROS include oxygen radicals such as 
diatomic oxygen (O2), superoxide anion (O2-), hydroxyl radical (OH), and peroxide ion 
(O22-). In addition to non-radicals, species such as hyperchlorous acid (HOCl), hydrogen 
peroxide (H2O2), and ozone (O3) are commonly present in biological systems and are also 
considered ROS. RNS include nitrogen-derived molecules, represented by the nitric oxide 
(NO) and its more oxidized counterparts. In biological systems, NO is catalyzed by a family 
of NADPH-dependent enzymes known as nitric oxide synthases (NOS). In mammals, there 
are three NOS isoforms named as neuronal (nNOS or NOS1), inducible (iNOS or NOS2) and 
endothelial (eNOS or NOS3). Depending on the circumstances or amount that  is generated, 
NO can act as signaling molecule (“low input NO”) or as defense substance against 
pathogens (“high input NO”). As a signaling molecule NO is generated in small amounts 
and exerts its function through generally reversible mild chemical reactions with protein 
amino acids or prosthetic groups, including reactions with heme centers in metalloproteins 
and thiol groups of cysteine amino acid. However, when NO is generated in high amounts 
and/or accompanied by other ROS, such as O2-, it undergoes multiple and complex 
oxidative reactions forming more oxidative and detrimental molecules, such as peroxynitrite 
(ONOO_), which is highly reactive to biomolecules (reaction 1).  
  (1) 
The concentration of NO is regulated both by its consumption in chemical reactions as well 
as its production in the cellular microenvironment. Consequently, as important as the 
enzymes that generate NO directly are the enzymes that control NOS activity indirectly. 
One of the indirect control mechanisms for NOS activity, in particular for iNOS, is the 
availability of its required substrate, L-arginine. L-arginine is not only a substrate for NOS, but 
also for arginases, enzymes that hydrolyze L-arginine to L-ornithine and urea (Diagram 1) 
(Lerzynski et al. 2006).  
 
 
Diagram 1. Simplified reaction demonstrating substrate competition between the enzymes 
NOS and arginase. 
Arginase, classically known as an enzyme within the urea cycle in the liver, is also found in 
many other cells and tissues including inflammatory cells (Munder 2009). There are two 
distinct isoforms of mammalian arginase, arginase I and arginase II (Morris 2009). The 
expression and activity of arginases are induced in murine models of allergic airways 
disease, as well as in patients with asthma (Zimmermann and Rothenberg 2006). It has been 
indicated that limitation of L-arginine availability, caused by activation of arginase, could 
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contribute to the loss of NO bioactivity (Ricciardolo et al. 2005; Maarsingh et al. 2006). In 
fact, the inhibition of arginase by the pharmacological arginase inhibitor, S-(2-boronoethyl)-
L-cysteine (BEC), decreased arginase activity and caused alterations in NO homeostasis, 
which were reflected by increases in NO-modified proteins in the lungs from inflamed mice. 
In addition, the same inhibitor enhanced perivascular and peribronchiolar lung 
inflammation, mucus metaplasia, genes of inflammatory chemokines, such as chemokine 
(C-C motif) ligand 20 (CCL20, which attracts neutrophils and dendritic cells) and 
keratinocyte chemoattractant (KC, responsible for attracting neutrophils). These results 
suggest that inhibition of arginase activity enhanced a variety of inflammatory parameters, 
possibly by altering NO homeostasis (Diagram 2) (Ckless et al. 2008). At the molecular level, 
arginase manipulation in lung epithelial cells can also impact NO homeostasis and affect 
inflammatory responses. In this scenario, the reduction of arginase activity enhances the 
general cellular content of NO and NO-modified proteins, including augmentation of NO-
modified nuclear factor kappa B (NF-κB), which has a major role in regulating immune and 
inflammatory responses. Interestingly, the effects of arginase inhibition on NF-κB is 
reversed by the generic NOS inhibitor, N-ω-nitro-L-arginine methyl ester (L-NAME), 
suggesting a causal role for NO in the attenuation of NF-κB induced by arginase 
suppression. Conversely, overexpression of arginase I decreases cellular NO-derivative 
content which causes decrease of NO-modified NF-κB. The aforementioned NO-
modification on NF-κB and other proteins includes S-nitrosylation, which will be discussed 
in more detail later in this chapter. Collectively, this study points out to a regulatory 
mechanism wherein NF-κB is controlled through arginase dependent regulation of NO 
levels, which may impact on chronic inflammatory diseases (Ckless et al. 2007). 
 
 
Diagram 2. Mechanism by which arginase might control NF-κB activity by decreasing NO 
availability. 
ROS can also be generated endogenously by several enzymatic and non-enzymatic 
reactions. In pathological, and perhaps physiological states, the major non-mitochondrial 
ROS sources are the enzymes called oxidases, which includes NADPH oxidases, and 
cyclooxygenases among others. In general the production of ROS by these non-
mitochondrial enzymes is dependent on a stimulus. Therefore in non-stimulated or in 
physiological conditions little is known about participation of these enzymes in ROS 
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generation. The generation of ROS by these non-mitocondrial enzymes in inflamed states 
will be discussed further in this chapter.  
The mitochondria can be a significant source of superoxide and nitric oxide in eukaryotic 
cells. The mitochondrial contribution to the pool of free radicals varies depending on cell 
function, and actively respiring mitochondria contribute more to the pool than do inactive 
mitochondria. Given that the standard reduction potential of O2 to O2- is -0.160 V and the 
standard reduction potentials of the redox centers in the respiratory chain range from -0.32 
V to +0.39 V, and the presence of substantial transition metals in the redox centers, it comes 
as no surprise that there is significant reactive species generation in this environment 
(Halliwell and Gutteridge 2007). Superoxide is generated on the outer mitochondrial 
membrane, on both surfaces of the mitochondrial intermembrane space, and within the 
matrix. Although superoxide generated within the matrix is dismutated by the many 
antioxidant defenses within the matrix, superoxide generated in the intermembrane space 
and on the surface of the outermembrane of the mitochondria may be carried into the 
cytoplasm by voltage-dependent anion channels (Halliwell and Gutteridge 2007). Under 
normal physiological conditions, electrons flow through the respiratory chain generating a 
proton gradient, pumping protons into the intermembranous space between the inner and 
outer mitochondrial membrane. The gradient then creates ATP as the protons flow through 
the ATP synthase. During times of low ADP concentration, proton flow through the ATP 
synthase is disrupted causing electron flow through the respiratory chain to slow, and the 
chain to become more reduced. It seems that the reduced state of the chain increases the rate 
of autoxidation of the redox centers by O2, forming O2-. It has been suggested that within 
the mitochondrial matrix, a unique form of NOS exists (Bustamante et al. 2007). The 
putative formation of NO in this environment has significant consequences due to its 
binding affinity to heme groups in the cytochromes of the respiratory chain. Additionally, 
the simultaneous production of O2- and NO can result in the production of peroxynitrite, 
which might inhibit important enzymes and disrupt mitochondrial integrity. Since the 
generation of NO requires oxygen, the rate of its generation is O2 dependent (Halliwell and 
Gutteridge 2007). 
Due to the increased ROS and RNS generation present in the mitochondria, antioxidant 
defenses have evolved to protect the integrity of the organelle. A family of metalloenzymes 
known as superoxide disumutases (SODs) catalyzes the formation of H2O2 and O2 from O2- 
and water. Although the dismutation of O2-  to H2O2 and water will occur spontaneously, 
SODs increase the rate of this diffusion in a controlled-manner. Within the mitochondrial 
matrix, a specific manganese containing SOD eliminates O2- from the matrix and the inner 
side of the inner mitochondrial membrane. Superoxide concentration in the intermembrane 
space is regulated by three mechanisms; a CuZnSOD, cytochrome c, and spontaneous 
dismutation induced by the lower pH of this area. In physiological conditions, H2O2  is 
rapidly decomposed by glutathione peroxidase and in some cell types by catalase. However 
if H2O2 accumulates it can be detrimental because it is the main precursor of the highly 
reactive hydroxyl radical, formed by interaction with reduced transition metals. In general 
the integrity of the mitochondrial membrane is maintained by a second glutathione 
peroxidase, known as phopholipid-hydroperoxide glutathione. This specialized peroxidase 
reduces lipid peroxides associated with the membrane. In addition to the “classical” 
antioxidant enzymes mitochondria integrity is also preserved by mitochondrial proteins 
that participate in the respiratory electron chain transport. It appears that the cytochrome c 
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electron carriers have a detoxifying role against ROS, ubiquinol (QH2) can act as a reducing 
agent in the elimination of peroxides in the presence of succinate, an intermediate of citric 
acid cycle. Non-enzymatic antioxidant systems also play a role in protecting mitochondrial 
integrity. The inner mitochondrial membrane contains high levels of vitamin E, a powerful 
antioxidant and inhibitor of free radical propagation reactions. 
3. Redox chemistry in inflammation states 
It is well known that chronic inflammatory diseases are associated with enhanced ROS and 
RNS production  exemplified by elevated levels of NO and H2O2 in the site of inflammation 
(Antczak et al. 1997; Emelyanov et al. 2001). These oxidants can be generated by enzymes 
abundant not only in inflammatory cells but also in non-inflammatory cells (Janssen-
Heininger et al. 2008). ROS and RNS generation in the inflammation site is typically induced 
as part of a defensive reaction intended to clear infectious and environmental threats, 
including microbial agents and particulate material. The resident and inflammatory 
hematopoietic-derived cells in the tissues possess oxidant-generating enzyme systems, 
including NADPH oxidase, which activity is mediated through the catalytic subunit gp91phox 
(NOX2) (Bedard and Krause 2007; van der Vliet 2008). This enzyme is capable of generating 
O2-, which spontaneously or enzymatically dismutates to H2O2 to further induce oxidation. 
ROS generation by non-hematopoietic NOXs is also very important. The non-hematopoietic 
ROS are generated by a family of enzymes, including, NOX1, NOX3, and NOX4, which 
function distinct from gp91phox (van de Veerdonk et al. 2010). In addition, some cell types 
such as epithelial cells have been described to produce active DUOX enzymes capable of 
generating H2O2 (van der Vliet 2008). Stimulated cells such as respiratory epithelium, 
neutrophils, and macrophages are also capable to produce NO in high amounts via  iNOS 
(Janssen-Heininger et al. 2002). Induction of both iNOS and NADPH oxidases at the 
inflammation site leads to simultaneous increases in O2.- and NO that  combine to form 
ONOO-, which ultimately can react with tyrosine residues in protein, forming the more 
stable product, nitrotyrosine (Diagram 3) (Brennan et al. 2002). Indeed, increased levels of 
NO in exhaled breath and protein nitration have been observed in patients with asthma, 
correlating NO with inflammation (Reszka et al. 2011).  
NO is highly diffusible, allowing it to potentially form ONOO- in areas spatially separated 
from the site of NO synthesis, limited only by its potent capacity to react with 
macromolecules (Lancaster and Gaston 2004). In addition, the reaction of NO with 
molecular oxygen (O2) yields nitrite (NO), which can be oxidized by hemeperoxidases to 
form NO2, thereby perpetuating the capacity for NO2 reactivity. NO2 is also formed when 
eosinophil peroxidase and myeloperoxidase, from eosinophils and neutrophils, respectively, 
consume NO and H2O2 (van der Vliet et al. 1999; Brennan et al. 2002). The environment 
can also be a source of NO2. In fact high levels of this gas can be found in the atmosphere, 
and it is associated with poor air quality caused by pollution in highly industrialized 
areas. NO2 primarily interacts with airway surface macromolecules, forming stable 
footprints of reactivity including the protein tyrosine modifications nitrotyrosine and 
dityrosine (Brennan et al. 2002), perhaps altering protein function. In addition, ONOO- or 
NO2 can decompose to form OH and H2O2, which can facilitate further oxidation and 
participate in intracellular signaling events. Therefore, exogenous or endogenous-
generated ROS and RNS may directly and indirectly affect cells that participate in the 
inflammatory and immune processes. 
www.intechopen.com
Inflammation, Chronic Diseases and Cancer –  
Cell and Molecular Biology, Immunology and Clinical Bases 
 
150 
 
Diagram 3. Generation  of peroxynitrite (ONOO-) in the inflammation site and potential 
reactions with proteins. 
The direct detection of ROS and RNS in situ of inflammation is an extremely challenging 
task. To overcome this difficulty, the detection of stable oxidation endproducts in proteins, 
such as nitrotyrosine, cysteine sulfenic (Cys-SOH), sulfinic (Cys-SO2H) and sulfonic (Cys-
SO3H) acids is a feasible approach to indicate the presence of ROS and RNS. The chemistry 
of these oxidations is especially complex. NO generated endogenously by NOS can react 
indirectly with the tripeptide glutathione (GSH) and convert it to the S-nitrosothiol, called S-
nitrosoglutathione (GSNO). Consequently, NO can exert its effects directly or through its 
derivatives (GSNO), by mediating protein S-nitrosylation (Diagram 4). By definition,  
 
 
Diagram 4. Mechanism by which GSNO mediates S-nitrosylation of proteins and the role of 
enzyme GSNO reductase on the equilibrium of S-nitrosylated proteins. 
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protein S-nitrosylation is a covalent binding of NO to a cysteine residues in the proteins and 
it has been considered a mechanism of protein regulation (Numajiri et al. 2011). Up to date 
there is no identified enzyme that specifically and directly decomposes PSNO, however the 
enzyme GSNO reductase decomposes the S-nitrosothiol, GSNO and indirectly controls the 
protein S-nitrosylation. In more oxidized states, NO is further oxidized to ONOO- which is 
very well known as a nitrating agent of tyrosine residues in proteins (See above). The 
presence of these oxidized proteins has been considered “a biomarker” of inflammation.  
The redox changes on cysteine residues are very dynamic and complex. In fact, S-
nitrosothiols, such as GSNO can also mediate another Cys oxidation, called S-
glutathionylation. Similar to S-nitrosylation, protein S-glutathionylation (PSSG) is the 
covalent modification of cysteines with the tri-peptide, glutathione (GSH). The formation of 
PSSG follows a more transient form of Cys-protein oxidation, which can by initiated by 
H2O2 which oxidizes protein cysteine to its thiolate state (Cys-) and further to the unstable 
sulfenic acid (Cys-SOH). In the presence of high amounts of ROS, cysteine residues can also 
be further overoxidized to Cys-SO2H and Cys-SO3H. The susceptibility of cysteine to 
oxidation is proportionally dependent on the low pKa of this amino acid, indicating 
substantial specificity to these oxidation events. Different from protein S-nitrosylation, 
protein S-glutathionylation can be decomposed by specific enzymes. In physiologic settings, 
glutaredoxins act to specifically reverse S-glutathionylated proteins (Diagram 5). Similarly, 
the thioredoxin (Trx) system of enzymes catalyzes the reversible reduction of disulfides, 
thereby resulting in a reduced thiol on target protein, and a disulfide on Trx, which is 
subsequently reduced by thioredoxin reductase. The presence of these and other enzymes to   
 
 
Diagram 5. Simplified mechanism by which protein S-glutathionylation is mediated in 
biological systems. 
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directly or indirectly regulate the oxidation state of protein cysteines gives additional 
acceptance to the relevance of protein oxidation events in cell biology and disease (Janssen-
Heininger et al. 2008). 
Since protein S-glutathionylation is reversible and perhaps regulated by specific enzymes, 
this post-translational modification has emerged as a regulatory mechanism of proteins. 
While certain redox changes that occur in the inflamed and adjacent cells may well 
contribute to the inflammatory disease process, the exact mechanisms by which ROS and 
RNS participate in the inflammatory and immune responses has remained unknown. One 
emerging scenario is centered on the role of oxidants as signaling molecules critical to tissue 
homeostasis and innate host defense. This concept of ‘‘redox biology’’ is based on the 
recently gained appreciation that NO and H2O2 cause specific oxidations in target cysteines 
within proteins, which exert regulatory functions, depending on the protein that is being 
targeted. Proteins with several functions, ranging from membrane proteins and proteases to 
transcription factors, are regulated via S-nitrosylation, S-glutathionylation, or other forms of 
cysteine oxidation. In this context, the NF-κB is the most represented transcription factor 
that is redox regulated. 
4. Redox regulation of transcription factors controlling immune and 
inflammatory responses 
The transcription factor NF-κB has been considered the master regulator of both innate and 
adaptive immune responses and has been demonstrated to play a critical role in allergic 
airways disease. In addition, this transcription factor has been known for a long time as a 
“redox sensitive transcription factor”. Therefore, understanding the various facets of redox 
regulation of NF-κB and its targets offers the potential to advance our understanding of 
immune and inflammatory processes. The family of NF-κB comprises five related proteins: 
p50, p52, RelA (also known as p65), c-Rel, and RelB. These factors can homo- and 
heterodimerize through the rel homology domain. Only RelA, c-Rel, and RelB contain a 
transcriptional activation domain, while p50 and p52 lack this, and can only activate 
transcription through heterodimerization with RelA, c-Rel, or RelB (Hayden and Ghosh 
2004; Pantano et al. 2006). NF-κB is sequestered in the cytoplasm of unstimulated cells 
bound to IκB proteins. In response to a wide array of stimuli, IκB proteins are 
phosphorylated by the serine kinase; inhibitor of kappa B kinase (IKK). Phosphorylated IκBs 
are ubiquitinated and degraded by the 26S proteosome, unmasking the NF-κB nuclear 
localization signal, allowing NF-κB to accumulate in the nucleus. At least two parallel 
pathways of IKK-induced NF-κB have been described. In the canonical pathway, activation 
of IKK by many stimuli, including cytokine TNF-ǂ, TLR agonists, and IL-1ǃ leads to the 
phosphorylation of IkBǂ at Serines 32 and 36 (DiDonato et al. 1997). In the noncanonical 
pathway, NF-κB–inducing kinase (NIK) phosphorylates IKKǂ. IKKǂ subsequently 
phosphorylates p100, which causes its proteolytic processing to p52 (Karin 1999), allowing 
p52/RelB dimeric complexes to translocate to the nucleus (Hayden and Ghosh 2008). 
Activators of the noncanonical pathway include subsets of stimuli that include B cell–
activating factor (BAFF), lymphotoxin b (LTb), and CD40 ligand (CD40L), as well as 
lipopolysaccharide (LPS). It is generally held that the noncanonical pathway is necessary for 
the adaptive immune response, while the canonical pathway is required for the onset of the 
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innate immune response (Bonizzi et al. 1999), although crosstalk between these pathways 
exists to control the strength and duration of the transcriptional response (Ghosh and 
Hayden 2008).  
NF-κB activation, by diverse proinflammatory stimuli including IL-1ǃ, has been 
demonstrated to require ROS in part after activation of NADPH oxidases (Bonizzi et al. 
1999; Li and Engelhardt 2006), and mitochondrial ROS in certain contexts also can lead to 
activation of NF-κB (Chandel et al. 2001; Hughes et al. 2005). However, it is not clear 
whether the oxidative events triggered by those stimuli are temporal and therefore specific 
to components of the NF-κB pathway. In fact, the physiologic role for oxidants in the 
activation of NF-κB has been questioned by studies demonstrating that redox activation is 
cell type specific (Anderson et al. 1994; Brennan and O'Neill 1995), and that various 
antioxidants were nonspecific in their actions (Hayakawa et al. 2003). Evidence also exists 
that NADPH oxidase–induced ROS do not mediate NF-κB signaling, but lower the 
magnitude of its activation (Hayakawa et al. 2003). A number of reports demonstrate that 
oxidants can specifically inhibit the NF-κB pathway in lung epithelial cells via S-
nitrosylation or S-glutathionylation of cysteine 179 of IKKǃ (Reynaert et al. 2004; Reynaert et 
al. 2006), the same cysteine also targeted by anti-inflammatory cyclopentenone 
prostaglandins (Rossi et al. 2000). It is likely that additional cysteine oxidative events that 
include modification of p50 (Matthews et al. 1992) and RelA (Kelleher et al. 2007) also 
contribute to oxidative inhibition of NF-κB. These observations suggest that certain 
regulatory oxidative events could play important anti-inflammatory roles in tissues by 
limiting the activation of NF-κB. The redox regulation of NF-κB and perhaps other 
transcription factors and proteins involved in inflammatory and immune responses is 
extremely complex, and there are strong evidences that this process is cell type, ROS/RNS 
space-temporal dependent. A good illustration of this complexity is represented by several 
publications on post-translational modifications of the NF-κB pathway. In two separate 
studies, the same cell line but different sources of RNS were utilized to demonstrate that the 
NF-κB pathway is a target for redox regulation. In one study it has been demonstrated that 
exogenous S-nitrosothiols (an NO-derivative) cause S-nitrosylation of IKKǃ inhibiting it and 
consequently inhibiting NF-κB (Reynaert et al 2004). In contrast, the second study 
demonstrated that increases in endogenous S-nitrosothiols caused by arginase inhibition do 
not affect the extent of IKKǃ activity, but still attenuate the NF-κB pathway downstream of 
IKKǃ (Ckless et al 2007). This apparent inconsistency may stem from potentially different 
chemical forms of NO, concentration, or subcellular localization that arose after arginase 
suppression (endogenous generation of S-nitrosothiols) compared with extracellularly 
delivered S-nitrosothiols and this different scenario may impact different targets of NF-κB 
pathways. In fact, in the study where the S-nitrosolthiols were generated endogenously, the 
target for S-nitrosylation was the p50  subunit of NF-κB complex. The NF-κB pathway is also 
a target for other type of posttranslational modification induced by ROS. Indeed in airway 
epithelial cells, cysteine-179 of the IKKǃ regulatory kinase is a central target for oxidative 
inactivation by S-glutathionylation, caused by exogenous H2O2. The various conflicting 
mechanisms that are described for ROS and their role in NF-κB regulation and consequent 
antioxidants response to ROS generation may reflect on the complexity of the inflammatory 
processes. Recently it was suggested that acute inflammation possesses well balanced 
opposing arms, apoptosis and wound healing (Khatami 2008). Since NF-κB controls at least 
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in part apoptotic/antiapoptotic events of this process, misregulation of this transcription 
factor caused by oxidative stress could lead to an unbalance between apoptosis and wound 
healing and in addition to the co-existence of death and growth factors in tissues, could 
create an dysfunctional immune response potentially leading to chronic inflammation, 
autoimmune diseases and cancer. (Khatami 2008; Khatami 2009; Khatami 2011). 
5. RNS and ROS beyond transcription factors 
The Interleukin 1 (IL-1) family of cytokines is critical to the host response to infection, 
playing a variety of roles not only in the acute phase response from the liver, but also in 
alterations of metabolism, induction of fever, and lymphocyte activation (Dinarello 2009). 
Overproduction of IL-1ǃ, in particular, is thought to be responsible for a variety of  
autoinflammatory syndromes such as familial Mediterranean fever and Muckle-Wells 
syndrome, and is also a contributing factor in rheumatoid arthritis, gout, multiple sclerosis 
(in the animal model experimental autoimmune encephalomyelitis), Alzheimer’s Disease, 
and diabetes (Gris et al.2010 ; Masters et al. 2010 ; Zhou et al. 2010 ; Griffin et al. 2006; 
Daheshia and Yao 2008; Clutterbuck et al. 2009). IL-1ǃ is also a pathogenic mediator in 
several pulmonary disorders, including infection, asthma, ALI/ARDS, transplant rejection, 
COPD, PAH, sarcoidosis, asbestosis, and silicosis (Dorfmuller et al. 2003; Wanderer 2008; 
Soon et al. 2010). Setting IL-1ǃ apart from other acute phase cytokines such as IL-6 and TNF-
ǂ is the requirement for processing from an inactive pro-form to an active secreted form by 
caspase-1 cleavage, which itself is activated by the assembly of cytoplasmic inflammasome 
complexes, which are multiprotein complexes that can activate caspase-1 and ultimately 
lead to the processing and secretion of interleukin (IL)-1ǃ and IL-18 . A number of the NOD-
like receptor (NLR) family members can form inflammasomes. One of the best-studied 
members of the NLR family is NLRP3 (NOD-like receptors pyrin domain-containing 3). The 
activation of NLRP3 inflammasome facilitates the formation of a molecular platform for 
caspase1-dependent secretion of IL-1. It has been demonstrated that the mechanism of 
processing and secretion of mature IL-1 in myeloid cells is a multistep event. The initial 
event necessary is the synthesis and accumulation of the precursor proteins including pro–
IL-1ǃ and NLRP3 (“signal 1”), accomplished by a variety of stimuli, including danger- and 
pathogen- associated molecular pattern molecules (DAMPs and PAMPs, respectively). After 
priming, NLRP3 activation leads to recruitment of the adaptor protein ASC (apoptotic 
speck-like protein containing a CARD) and the enzyme caspase-1 to form the NLRP3 
inflammasome complex (“signal 2”), which ultimately is responsible for the cleavage and 
secretion of IL-1 (Diagram 6) (Martinon et al. 2009). The cleavage and secretion of IL-1 can 
be enhanced by release of endogenous ATP that stimulates the purinergic receptor P2X7 
(Piccini et al. 2008). Interestingly, several identified NLRP3 activators also trigger reactive 
oxygen species (ROS) production. It is well documented that activation of P2X7 is 
accompanied by production of ROS, produced at least in part by NADPH oxidases (Cruz et 
al. 2007; Dostert et al. 2008).  
In the context of redox regulation of target proteins, what appears to be highly significant is 
the cellular location and quantity of ROS generated. Overall, several studies using 
antioxidants support a model in which ROS production by NLRP3 agonists drive 
inflammasome assembly (Tschopp and Schroder, 2010). The initial idea that NADPH 
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oxidases are the primary source of ROS production during inflammasome activation is 
becoming less accepted. Two independent studies utilizing mononlucear phagocytes from 
patients with granulomatous disease, who because of mutation in p47phox have defective 
NADPH activity, demonstrated that there is IL-1 secretion from these inflammatory cells 
upon stimulation, despite the fact that these cells cannot generate NADPH oxidase-
dependent ROS. (Meissner et al. 2010; van de Veerdonk et al.,2010). Since NADPH oxidase 
may not be the only source of ROS in the cells, the importance of mitochondrial-derived 
ROS has been recently explored. The mitochondria is the main source of ROS under 
physiological conditions, however under conditions of cellular stress, including increases in 
metabolic rates, hypoxia or cellular disruption, the mitochondria can generate increased 
amount of ROS (Brookes et al. 2004). In fact, blockage of key enzymes of the respiratory 
chain leads to ROS generation and consequent NLRP3 inflammasome activation (Zhou et al. 
2010). Since NLRP3 de novo synthesis is an essential step in the activity of NLRP3, the 
temporal generation of ROS is also another important aspect to be considered to understand 
the role of these species in controlling NLRP3 inflammasome activation. In fact it has been 
recently published that ROS are important for de novo synthesis of NLRP3, but not 
activation. However, this evidence does not exclude a general role for ROS in the process of 
NLRP3-triggered inflammation (Bauernfeind et al. 2011). Despite several high profile 
publications in the field, the mechanisms of production and the nature of ROS involvement 
in inflammasome activation remain the subject of intense scrutiny.  
 
 
Diagram 6. Suggested mechanism of NLRP3 inflammasome activation and IL-1ǃ secretion. 
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6. Conclusions 
ROS and RNS are active participants in complex biological processes, including innate and 
immune responses. Whether the sources of ROS and RNS are environmental (exogenous 
sources) or are generated endogenously, they can affect several steps involved in these 
processes. It is critical to take in consideration that individual cells and multicellular 
organisms have developed intricate mechanisms to utilize ROS and RNS to modulate 
homeostasis and respond to threats. Therefore, generalized therapeutic and prophylactic 
approaches to modulate ROS and RNS generation and reactivity may not represent realistic 
tools to prevent or treat inflammatory diseases. Therefore, a better understanding of the 
sequence of events leading to specific immune and inflammatory responses, the temporal 
and spatial generation of ROS and RNS, and the potential molecular targets of oxidative 
modification, may provide crucial knowledge for the future development of more effective 
alternative therapeutic interventions in combination with the current ones to improve 
quality of life of patients with chronic inflammatory and auto-immune diseases 
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